MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea

Citations Over TimeTop 15% of 2016 papers

Abstract

MK2 activation by p38 MAPK selectively induces inflammation in various diseases. We determined if a MK2 inhibitor (MK2i), improves cornea wound healing by inhibiting inflammation caused by burning rat corneas with alkali. Our study, for the first time, demonstrated that MK2i inhibited alkali burn-induced MK2 activation as well as rises in inflammation based on: a) blunting rises in inflammatory index, inflammatory cell infiltration, ED1(+) macrophage and PMN(+) neutrophil infiltration; b) suppressing IL-6 and IL-1β gene expression along with those of macrophage inflammatory protein-1α (MIP-1α), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1); c) reducing angiogenic gene expression levels and neovascularization (NV) whereas anti-angiogenic PEDF levels increased. In addition, this study found that MK2i did not affect human corneal epithelial cell (HCEC) proliferation and migration and had no detectable side effects on ocular surface integrity. Taken together, MK2i selectively inhibited alkali burn-induced corneal inflammation by blocking MK2 activation, these effects have clinical relevance in the treatment of inflammation related ocular surface diseases.

Related Papers

• → Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice(2004)57 cited
• → PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression(2012)45 cited
• → Effects of Laser Photocoagulation on Corneal Neovascularization in Rabbits(1994)7 cited
• → Cyclosporine and neovascularization: Authors’ reply(1999)
• The Expression of MMP_2,VEGF in Inflammation -associated Corneal Neovascularization and Relational Study(2002)